Healthcare Earnings Q4 2025 Roundup
Healthcare Earnings Q4 2025 Roundup: 4 Companies Analyzed
Sector Overview
The Healthcare sector saw 4 companies report earnings this quarter. Average revenue growth across the sector was +3.8%, indicating steady but moderate growth. On average, stocks moved -2.0% on earnings day, with 2 out of 4 companies seeing positive reactions.
Combined sector revenue totaled $243.1B for the quarter.
Company-by-Company Results
| Company | Ticker | Revenue | YoY Change | Earnings Day Move |
|---|---|---|---|---|
| CVS Health Corporation | CVS | $105.7B | +8.2% | -0.2% |
| GE Health Care | GEHC | $4.7B | -12.1% | +4.9% |
| HCA Healthcare | HCA | $19.5B | +6.7% | +7.1% |
| UnitedHealth Group Incorporated | UNH | $113.2B | +12.3% | -19.6% |
Top Performers
UnitedHealth Group Incorporated (UNH) led the sector with revenue growth of +12.3%. Integrated MA, OptumHealth, and OptumRx platform plus AI-driven productivity and disciplined repricing allow UNH to absorb government funding pressure and return to its 13–16% EPS growth algorithm with expanding margins.
CVS Health Corporation (CVS) led the sector with revenue growth of +8.2%. CVS leverages MA margin recovery, resilient PBM economics, and scalable tech-enabled retail and engagement platforms to unlock its embedded earnings power and sustain mid-teens EPS growth through 2028.
HCA Healthcare (HCA) led the sector with revenue growth of +6.7%. HCA’s investments in AI, outpatient expansion, and resiliency programs position it for sustained growth and margin stability despite near-term headwinds.
Underperformers
GE Health Care (GEHC) reported revenue growth of -12.1%. China weakness, execution and logistics risk around Vorcado and the NPI wave, and reliance on self-help and pricing in a potentially peaking CapEx cycle could prevent GE HealthCare from achieving its mid-term growth and margin targets.
HCA Healthcare (HCA) reported revenue growth of +6.7%. ACA subsidy expiration and supplemental payment declines will pressure volumes and margins, creating uncertainty around long-term profitability.
CVS Health Corporation (CVS) reported revenue growth of +8.2%. Persistent regulatory and reimbursement pressure in MA and PBM, combined with elevated medical trends and heavy tech investment, prevent CVS from achieving target margins and its long-term earnings growth algorithm.
Key Themes Across the Sector
Across 4 earnings calls, several common themes emerged:
- Sustainability of Medicare Advantage Margins and 2027 Rate Risk
- Regulatory / Legislative Overhang on the PBM and Durability of Caremark Margins
- Sustainability of Orders Growth, Backlog Quality, and 2026 Revenue Guide (incl. China drag)
- EPS Growth Algorithm, Margin Expansion, and Tariff Mitigation / Heartbeat “Self‑Help”
- Impact of ACA Subsidy Expiration and Exchange Headwinds on 2026 Guidance
Individual Earnings Reports
- CVS Health Corporation (CVS) Q4 2025 Earnings
- GE Health Care (GEHC) Q4 2025 Earnings
- HCA Healthcare (HCA) Q4 2025 Earnings
- UnitedHealth Group Incorporated (UNH) Q4 2025 Earnings
Frequently Asked Questions
How did the healthcare sector perform in Q4 2025?
The healthcare sector saw average revenue growth of +3.8% across 4 companies that reported earnings. The top performer was UnitedHealth Group Incorporated (UNH) with revenue growth of +12.3%.
Which healthcare stock performed best after earnings?
HCA Healthcare (HCA) had the strongest earnings-day reaction, with the stock moving +7.1% on the report.
What are the key trends in healthcare for 2025?
Key themes discussed across healthcare earnings calls include: sustainability of orders growth, backlog quality, and 2026 revenue guide (incl. china drag), impact of aca subsidy expiration and exchange headwinds on 2026 guidance, regulatory / legislative overhang on the pbm and durability of caremark margins. These topics were debated across multiple companies in the sector.
This roundup was generated by Calypso, an AI-powered equity research platform. For real-time earnings analysis, interactive debates, and coverage of 400+ stocks, try Calypso free.